Pharmacological Probes to Validate Biomarkers for Analgesic Drug Development

There is an urgent need for analgesics with improved efficacy, especially in neuropathic and other chronic pain conditions. Unfortunately, in recent decades, many candidate analgesics have failed in clinical phase II or III trials despite promising preclinical results. Translational assessment tools...

Descripción completa

Detalles Bibliográficos
Autores principales: van Niel, Johannes, Bloms-Funke, Petra, Caspani, Ombretta, Cendros, Jose Maria, Garcia-Larrea, Luis, Truini, Andrea, Tracey, Irene, Chapman, Sonya C., Marco-Ariño, Nicolás, Troconiz, Iñaki F., Phillips, Keith, Finnerup, Nanna Brix, Mouraux, André, Treede, Rolf-Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368481/
https://www.ncbi.nlm.nih.gov/pubmed/35955432
http://dx.doi.org/10.3390/ijms23158295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368481/
https://www.ncbi.nlm.nih.gov/pubmed/35955432
http://dx.doi.org/10.3390/ijms23158295

Ejemplares similares